Department of Maternal Child Health, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States of America.
PLoS One. 2023 Nov 22;18(11):e0294604. doi: 10.1371/journal.pone.0294604. eCollection 2023.
Research ethics guidelines and emphasis on representation in research guide the inclusion of marginalized groups, including people with perinatal opioid use disorders (OUD) and people experiencing incarceration in the United States. However, insights from participants regarding the risks and benefits of participation are not adequately considered. The aim of this study was to examine the risks and benefits of research participation from the perspective of pregnant/postpartum people with OUD who have experienced incarceration.
We recruited people who had experience with perinatal incarceration and were either currently pregnant or postpartum, and at least 18 years old. All participants met the clinical criteria for OUD. Our study did not have exclusion criteria based on gender, race, or ethnicity.
Participants were either currently incarcerated at the North Carolina Correctional Institute for Women in Raleigh, North Carolina, United States or had previously experienced perinatal incarceration and were recruited from a perinatal substance use disorder treatment program located in North Carolina.
Between 9/2021-4/2022, we completed 12 interviews with pregnant/postpartum people with OUD, approximately half who were currently incarcerated and half with a recent history of perinatal incarceration.
INTERVENTION/MEASUREMENT: Interviews were conducted via Webex phone or video. The interviews followed a scripted interview guide and lasted one hour on average. Interview transcripts were analyzed using the Rigorous and Accelerated Data Reduction technique to produce an overarching thematic framework.
Our analysis identified benefits, including the personal advantage of self-expression, helping others and contributing to change, and financial incentives. Risks included stigma and breach of confidentiality, misunderstanding of the distinction between research and advocacy, and limited ability to share their whole experience.
Participant-identified benefits of research mirrored those from other marginalized populations, though participant-identified risks were novel and nuanced. Recruitment and consent should move beyond normative research ethics committees protocol language to consider the perspectives of participants.
研究伦理准则和对研究代表性的重视指导着边缘化群体的纳入,包括患有围产期阿片类药物使用障碍(OUD)和在美国经历监禁的人。然而,参与者对于参与研究的风险和益处的看法并没有得到充分考虑。本研究旨在从经历过监禁的围产期 OUD 患者的角度探讨参与研究的风险和益处。
我们招募了有围产期监禁经历且至少 18 岁的孕妇/产后女性,要么正在怀孕,要么刚刚分娩。所有参与者均符合 OUD 的临床标准。我们的研究没有基于性别、种族或民族的排除标准。
参与者要么目前被关押在北卡罗来纳州罗利市的北卡罗来纳女子惩教所,要么之前有过围产期监禁经历,是从位于北卡罗来纳州的围产期物质使用障碍治疗计划中招募的。
在 2021 年 9 月至 2022 年 4 月期间,我们完成了 12 次对患有 OUD 的孕妇/产后女性的访谈,其中大约一半目前被监禁,一半有近期围产期监禁史。
干预/措施:访谈通过 Webex 电话或视频进行。访谈遵循脚本式访谈指南,平均持续一个小时。访谈记录采用严格加速数据减少技术进行分析,以生成一个总体主题框架。
我们的分析确定了一些益处,包括自我表达、帮助他人和为变革做出贡献的个人优势,以及经济激励。风险包括耻辱感和机密性泄露、对研究和宣传之间区别的误解,以及有限的能力来分享他们的全部经历。
参与者确定的研究益处与其他边缘化群体的益处相似,尽管参与者确定的风险是新颖而微妙的。招募和同意应该超越规范的研究伦理委员会协议语言,考虑参与者的观点。